Adage Capital Partners GP »

Monte Rosa Therapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.1M 250k 16.45

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
ConocoPhillips (COP)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Revolution Medicines (RVMD)

View all positions for Adage Capital Partners GP

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
TCG Crossover Management
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vestal Point Capital
State Street Corporation
Braidwell
Versant Venture Management
Vanguard Capital Management
American Century Companies
Silverarc Capital Management
Aisling Capital Management
Geode Capital Management

View all funds holding Monte Rosa Therapeutics